On September 2, Beauty Farm Medical Health (02373.HK) submitted its monthly securities movement report to the Hong Kong Exchanges and Clearing Limited, covering the period ended August 31, 2026. During August 2026, the company repurchased 30,000 ordinary shares at HKD 19.09 per share, holding them as treasury stock. This buyback was authorized at the shareholders' meeting on June 26, 2026, with the event date recorded as July 31, 2026.

Following the repurchase, the number of issued shares (excluding treasury shares) remained at 248 million compared to the previous month's close, while treasury shares increased from 3.503 million to 3.533 million. The total issued shares stayed unchanged at 252 million. There were no changes to the authorized or registered share capital during the month, with the month-end balance maintaining 10 billion shares at a par value of USD 0.000005 per share, bringing the total authorized capital to USD 50,000.

The company confirmed that it met the minimum public float requirements as of the end of the reporting month. The report was submitted by Director Li Yang.